In a large cohort of women with locally advanced breast cancer treated with NAC, we have shown that expression of ALDH1, a marker of stem-like cancer cells, strongly predicts for innate resistance to sequential FEC/TAX chemotherapy. Here, ALDH1A1 is linked to breast cancer.